Several people, knowing of my prior experience with other mass tort cases like asbestos and Vioxx, have called me recently to ask if my office is handling Cipro lawsuit cases in NY and PA? The answer is Yes, we are.
For those of you who do not know what a “Cipro lawsuit” is, I will explain in detail below. But before doing that I thought it would be useful to explain how my firm, a small firm in Upstate NY with attorneys admitted in NY and PA, handles what are essentially national mass tort cases. How do the Davids fight the Goliaths? How do the “little guys” fight the drug company “giants”?
We do so by smart collaboration with other attorneys all over the country (and sometimes, all over the world). For technologically savvy attorneys, the old days of having to “go it alone” are long over. Today, with the tools of the internet, listservs, web conferencing and database sharing, I can sit in my office in Elmira, NY and have access to the information a lawyer as close as Rochester, NY or as far away as China, has just learned in his case. I can download and search millions of pages of documents that were scanned in a warehouse in Mississippi. I can pick the brains of my fellow attorneys handling the same types of cases.
In the appropriate mass tort case, I can associate with national class counsel for their assistance in representing my client. When we do this, the client does NOT pay a single penny more in fees than if I chose to handle the case on my own so it’s a Win/Win for my clients– they get the benefit of the personal attention of a smaller firm while having the firepower of a larger national firm while still paying the same attorney fee (almost always, 1/3rd of the amount recovered after deduction of expenses).
Over the years, my firm has had great success handling these cases and we look forward to doing the same with the Cipro cases. So let me explain what a Cipro lawsuit is all about.
First some background. Cipro (Ciprofloxacin) is an antibiotic manufactured and sold by Bayer A.G. and is also marketed under the brand names Ciproxin and Ciprobay. Cipro belongs to a group of antibiotics called fluoroquinolones that are prescribed to fight many types of bacterial infections. Cipro has been linked to an increased risk of tendon ruptures, tendonitis, and other serious injuries in users.
In July, 2008, the FDA announced it would require a “black box” warning on all Cipro prescriptions. The “black box” warning is the most serious warning that the FDA can require of prescription medication. In the case of Cipro, the warning was required due to the increasing incidence of cases of tendon ruptures, a serious injury that can leave patients incapacitated and needing extensive surgery. The tendon ruptures have increasingly occurred among patients taking Cipro and other fluoroquinolone antibiotics. The drug types within the fluoroquinolone family include:
* Levaquin (levofloxacin).
* Factive (gemifloxacin mesylate).
* Avelox (moxifloxacin HCL).
*Cipro XR and Proquin XR (ciprofloxacin extended release).
*Noroxin (norfloxacin).
*Floxin (ofloxacin).
*Cipro (ciprofloaxacin).
Hundreds of Cipro users have suffered painful tendon ruptures and tendonitis, particularly in the shoulder, hand, and Achilles tendon in the foot. Tendons are cords of tissue that join muscles and bones and are essential in movement.
People injured by Cipro may be eligible to be financially compensated for their medical bills, pain and suffering, lost wages, and other damages. If you have been seriously injured as a result of taking Cipro, you should immediately consult an experienced injury attorney to determine your legal rights.
I hope you found this information helpful but if you have any questions, feel free to post them in the Comments below or email me directly at jreed@zifflaw.com.
Thanks for reading,
Jim Reed
NY & PA Accident & Malpractice Lawyer
Elmira, NY
My Bio
Here are some Cipro articles for additional information:
- Fluoroquinolones Receive Black Box Label by Fda
- U.S. drug safety officials require stronger warning on some antibiotics
- FDA Warns Of Tendon Risk For Antibiotics